Joint Subcommittee Hearing: BioWatch Present and Future: Meeting Mission Needs for Effective Biosurveillance?
Chairman Bilirakis on the hearing: "The Subcommittee on Emergency Preparedness, Response, and Communications and the Subcommittee on Cybersecurity, Infrastructure Protection, and Security Technologies have conducted extensive oversight over BioWatch throughout the 112th Congress. This hearing continues this important oversight of the Department of Homeland Security's biosurveillance capabilities, and will pay particular attention to the capabilities of BioWatch Generation 1/2 and the procurement of the next generation of BioWatch, known as Gen-3. With an estimated life cycle cost of $5.8 billion, the Gen-3 procurement is one of the most costly at the Department of Homeland Security. We must ensure that the development and procurement of the next generation of BioWatch is based on sound science and that we are getting an appropriate return on our investment. This hearing will provide Members of the Subcommittees an opportunity to consider the efficiency and effectiveness of BioWatch, particularly through the lens of analysis prepared by the Government Accountability Office at the request of Chairman Lungren and myself."
Opening Statements
Rep. Gus Bilirakis (R-FL), Chairman, Subcommittee on Emergency Preparedness, Response, and Communications
Rep. Dan Lungren (R-CA), Chairman, Subcommittee on Cybersecurity, Infrastructure Protection, and Security Technologies
[full text of opening statements available upon commencement of hearing]
Witnesses
Dr. Alexander Garza, MD, MPH
Assistant Secretary for Health Affairs
Chief Medical Officer
U.S. Department of Homeland Security
Hon. Rafael Borras
Under Secretary for Management
U.S. Department of Homeland Security
Mr. William Jenkins
Director
Homeland Security and Justice Issues
Government Accountability Office
Dr. Albert J. Romanosky, MD, PhD
Medical Director/State Emergency Preparedness Coordinator
Office of Preparedness and Response
Department of Health and Mental Hygiene
State of Maryland
[full text of testimonies available upon commencement of hearing]